Oscar Health, Inc. (NYSE:OSCR) Given Consensus Recommendation of “Reduce” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been assigned an average recommendation of “Reduce” from the seven analysts that are currently covering the company, Marketbeat reports. Three analysts have rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the company. The average 12 month price objective among analysts that have issued a report on the stock in the last year is $16.58.

A number of brokerages recently weighed in on OSCR. Raymond James Financial lowered Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Wells Fargo & Company lowered Oscar Health from an “overweight” rating to an “equal weight” rating and lowered their target price for the company from $20.00 to $16.00 in a report on Thursday, March 13th. Piper Sandler lowered their target price on Oscar Health from $25.00 to $18.00 and set an “overweight” rating on the stock in a report on Monday, June 9th. Barclays assumed coverage on Oscar Health in a report on Wednesday. They issued an “underweight” rating and a $17.00 target price on the stock. Finally, Wall Street Zen lowered Oscar Health from a “buy” rating to a “hold” rating in a report on Sunday, June 8th.

Insider Activity at Oscar Health

In related news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction dated Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director directly owned 64,512 shares in the company, valued at approximately $1,059,932.16. This represents a 27.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 24.39% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Oscar Health

Large investors have recently added to or reduced their stakes in the business. Jones Financial Companies Lllp lifted its position in Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares during the period. Strs Ohio purchased a new position in Oscar Health during the first quarter worth about $30,000. Larson Financial Group LLC lifted its position in Oscar Health by 83,733.3% during the first quarter. Larson Financial Group LLC now owns 2,515 shares of the company’s stock worth $33,000 after buying an additional 2,512 shares during the period. CWM LLC lifted its position in Oscar Health by 50.7% during the first quarter. CWM LLC now owns 3,204 shares of the company’s stock worth $42,000 after buying an additional 1,078 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its position in Oscar Health by 484.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,443 shares of the company’s stock worth $45,000 after buying an additional 2,854 shares during the period. 75.70% of the stock is currently owned by hedge funds and other institutional investors.

Oscar Health Trading Down 0.6%

Shares of OSCR stock opened at $16.52 on Friday. The business’s fifty day moving average price is $16.02 and its 200 day moving average price is $14.81. Oscar Health has a 1-year low of $11.20 and a 1-year high of $23.79. The firm has a market capitalization of $4.21 billion, a PE ratio of 59.00 and a beta of 1.90. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.88 and a quick ratio of 0.88.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.09. Oscar Health had a return on equity of 10.59% and a net margin of 1.22%. The firm had revenue of $3 billion for the quarter, compared to analyst estimates of $2.87 billion. During the same quarter in the prior year, the company posted $0.62 earnings per share. Oscar Health’s quarterly revenue was up 42.2% on a year-over-year basis. As a group, sell-side analysts forecast that Oscar Health will post 0.69 EPS for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.